Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2345${count})

  • MJFF Research Grant, 2013
    Angiogenic Biomarkers in PD Dementia: Clinical-Biochemical-Pathological Correlations

    Objective/Rationale: 

    Many patients with Parkinson´s disease (PD) eventually develop dementia, a severe form of cognitive deterioration, and widespread neurodegenerative processes affecting the...

  • Rapid Response Innovation Awards, 2013
    Enteric Glial Cells as a New Source of Biomarkers for PD

    Objective/Rationale: 
    The neural network of the gut called the enteric nervous system (ENS) is affected by the pathological process in PD. One of the relevant features of the ENS is its accessibility...

  • Rapid Response Innovation Awards, 2013
    Protease-Activated Receptor-2 Expression in Parkinson’s Disease

    Objective/Rationale:             
    Inflammation in the brain (neuroinflammation) is an ongoing process in Parkinson's disease and contributes to cell death. Anti-inflammatory compounds are...

  • Rapid Response Innovation Awards, 2013
    The Influence of Bacterial Amyloid on Alpha-synuclein Misfolding in a Pre-clinical Model

    Objective/Rationale:             
    In Parkinson’s disease (PD), in nerve cells in the brain and in the intestine, alpha-synuclein proteins are misformed with abnormal folds and develop small toxic...

  • MJFF Research Grant, 2013
    LRRK2 PET Tracer Development

    Promising Outcomes of Original Grant:
    With our initial grant from MJFF, we focused on designing and synthesizing chemical matter with physico-chemical properties such that it could travel into the...

  • Target Validation, 2013
    Effects of IL-10 on Neurodegeneration in Mutant Alpha-Synuclein Transgenic Models

    Objective/Rationale:             
    One of the hallmark pathologies in the brains of patients with Parkinson’s disease (PD) is an inflammatory response. We will test whether the cytokine interleukin-10...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.